Skip to main content
This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.

Analysts Are Bullish on Top Financial Stocks: Federal National Mortgage Association (FNMA), Assurant (AIZ)

Tipranks - Fri Feb 13, 9:06AM CST

There’s a lot to be optimistic about in the Financial sector as 2 analysts just weighed in on Federal National Mortgage Association (FNMAResearch Report) and Assurant (AIZResearch Report) with bullish sentiments.

Valentine's Day Sale - 70% Off

Federal National Mortgage Association (FNMA)

Wedbush analyst Henry Coffey maintained a Buy rating on Federal National Mortgage Association today and set a price target of $13.00. The company’s shares closed last Thursday at $8.25.

According to TipRanks.com, Coffey is ranked #612 out of 12109 analysts.

The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Federal National Mortgage Association with a $13.83 average price target, implying a 66.8% upside from current levels. In a report released yesterday, BTIG also maintained a Buy rating on the stock with a $20.00 price target.

See the top stocks recommended by analysts >>

Assurant (AIZ)

William Blair analyst Jeff Schmitt maintained a Buy rating on Assurant today. The company’s shares closed last Thursday at $218.84, close to its 52-week high of $230.55.

According to TipRanks.com, Schmitt is a 4-star analyst with an average return of 9.9% and a 70.3% success rate. Schmitt covers the Financial sector, focusing on stocks such as Miami International Holdings, Inc., SEI Investments Company, and Marketaxess Holdings. ;'>

Currently, the analyst consensus on Assurant is a Strong Buy with an average price target of $258.40, which is a 18.3% upside from current levels. In a report issued on January 29, TipRanks – OpenAI also downgraded the stock to Buy with a $265.00 price target.

Disclaimer & DisclosureReport an Issue

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.